At a glance
ClinicalIndex Comparison RecordN/ACompleted· 66 target
Drug / intervention
Ankle Dorsiflexion Dynasplint Systemdevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Plantar Fasciopathy Treated With Dynamic Splinting: A Randomized, Controlled, Cross-Over Study
In Brief
A clinical study evaluating Ankle Dorsiflexion Dynasplint System for Plantar Fasciitis. Completed, enrolled 66 participants across 4 sites.
Detailed Summary
The purpose of this study is to determine if the Ankle Dorsiflexion Dynasplint System (DS) is effective in reducing pain from Plantar Fasciitis (Fasciopathy).
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsPlantar Fasciitis
CountriesUnited States
Collaborators--
Timeline
N/ACompletedFinished
20082009201020112012201320142015201620172018201920202021202220232024202520262027
Enrollment StartFeb 2008
First PostedApr 2008
Primary CompletionJan 2009
TodayJul 2026
First PostedApr 2, 2008
Enrollment StartFeb 1, 2008
Primary CompletionJan 1, 2009
TodayJul 2, 2026
Enrollment to primary: 11 monthsPosted 18.3 years ago
Interventions
Ankle Dorsiflexion Dynasplint Systemdevice
Dynamic Splinting utilizes the protocols of Low-Load, Prolonged-Duration Stretch (LLPS) with calibrated, adjustable tension to increase the Total End Range Time (TERT) to reduce contracture. This unit is worn at night while sleeping (6-8 hours) and, this does not affect activities of daily living.